Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT01612390 Not yet recruiting - Clinical trials for Postpartum Hemorrhage Prevention by Using Oxytocin Verses Misoprostol

Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor

Start date: August 2012
Phase: Phase 0
Study type: Observational

Sublingual misoprostol is superior to oxytocin in reduction of blood loss during the third and fourth stages of labor

NCT ID: NCT01608971 Completed - Bleeding Clinical Trials

Protamine in Cardiac Surgery and Haemostasis

PROTT
Start date: January 2011
Phase: N/A
Study type: Observational

Protamine is used after Cardiopulmonary Bypass (CPB) to reverse the anticoagulant effects of heparin and restore coagulation. Convincing evidence from in-vitro and in-vivo studies suggest that an overdose of protamine has anticoagulant effects which might lead to bleeding complications. Heparin levels usually decrease during cardiac surgery with CPB. Therefore, a protamine regimen based on the initial heparin dose before CPB might lead to overdose of protamine. In contrast, a protamine regimen based on the actual heparin concentration may avoid this condition. The investigators compare both regimens of protamine dosing in patients undergoing complex surgery with CPB and assess its effect on the amount of protamine given, markers of the coagulation system, utilization of blood products and perioperative blood loss.

NCT ID: NCT01608958 Completed - Clinical trials for Postpartum Hemorrhage

IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage

Start date: May 2012
Phase: N/A
Study type: Interventional

The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via IV infusion results in a lower mean blood loss compared to IM injection.

NCT ID: NCT01607151 Active, not recruiting - Clinical trials for Intracerebral Hemorrhage

Safety and Feasibility Study of Targeted Temperature Management After ICH

TTM-ICH
Start date: January 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Though TTM is ubiquitously used in the neuro-intensive care unit, there is limited experience with the use of TTM after intracerebral hemorrhage (ICH), the most devastating type of stroke. TTM may be a an intervention to improve patient outcomes. This trial addresses the safety and tolerability of a protocol of ultra-early TTM after ICH/IPH and may be the basis for future larger clinical trials.

NCT ID: NCT01606865 Completed - Clinical trials for Postoperative Bleeding

Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery

BIANCA
Start date: September 2010
Phase: N/A
Study type: Observational

The aim of the study is to evaluate if there is an association between platelet inhibition and surgery-related bleeding in patients undergoing non-cardiac surgery during dual antiplatelet therapy.

NCT ID: NCT01605903 Completed - Tonsillectomy Clinical Trials

Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy

Start date: May 3, 2012
Phase: Phase 2
Study type: Interventional

Tonsillectomy (the surgical removal of the tonsils) is a commonly performed surgery in children. One risk of tonsillectomy is postoperative bleeding, and this can be more dangerous in children because their blood volume is lower than adults. Ibuprofen, a nonsteroidal anti-inflammatory medication (NSAID), is an effective pain medication. Recent guidelines, published by the American Academy of Otolaryngology, advocated use of ibuprofen after tonsillectomy. However, NSAIDs are associated with altered platelet function and a theoretical increased risk of bleeding after surgery. The investigators would like to explore the effect that ibuprofen has on postoperative bleeding, as well as validate previous studies demonstrating it is an effective pain medication after tonsillectomy.

NCT ID: NCT01600612 Recruiting - Clinical trials for Postpartum Hemorrhage

Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial

Start date: September 2012
Phase: N/A
Study type: Interventional

Postpartum hemorrhage (PPH) is the leading cause of maternal death worldwide, with an estimated mortality of 140 000 per year. Uterine atony is one of the most important causes of PPH. The traditional treatment of which is the use of uterotonic agents. Oxytocin is the most conventional drug which was proved effective. However, it has the shortcomings of short half life and the necessity of intravenous administration. Misopristol, and more recently Carbetocin were introduced for treatment of atonic PPP not responding to Oxytocin. Aim of the study is to evaluate the effectiveness of Carbetocin, Misopristol, and Oxytocin for treatment of atonic PPH.

NCT ID: NCT01600599 Completed - Post CABG Bleeding Clinical Trials

Reducing Post Operative Bleeding Following Cabg

LATA
Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of IV Tranexamic Acid and topical Tranexamic Acid to control post op bleeding following Coronary Artery Bypass Graft Surgery using Cardiopulmonary Bypass.

NCT ID: NCT01599468 Completed - Clinical trials for Post Partum Hemorrhage

Can Tranexamic Acid Reduce Bleeding After Post Partum Hemorrhage in Cesarean Section Delivery

Start date: July 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study was to evaluate the effect of early administration of tranexamic acid (TXA) on post partum hemorrhage caused by uterine atony after cesarean section delivery. This was a randomised, placebo controlled trial including 74 patients. The investigators included ASA1 parturients with correct haemostatic status undergoing cesarean section under spinal anesthesia. The randomization begins after the inefficacy of oxytocin injections and starting up sulprostone perfusion at the request of the surgeon. TXA Group received 10 mg/kg of tranexamic acid as induction dose within 12 minutes and 1mg/Kg/h as maintenance within the 2 following hours. Placebo Group received same volumes of normal saline. The investigators compared blood loss and transfusions in both groups.

NCT ID: NCT01594671 Completed - Blood Loss Clinical Trials

Tranexamic Acid for Unilateral Total Knee Arthroplasty

TRANEXTOP
Start date: February 2012
Phase: Phase 3
Study type: Interventional

Total knee arthroplasty is often associated with excessive postoperative bleeding due to increased fibrinolysis. Hence, the objective of the proposed of this multicentre study is to determine the peri-operative bleeding comparing the application of topical and intravenous tranexamic acid with the habitual surgical haemostasis.